V

Varian

Tech-enabled radiation oncology hardware and software

IMMULITE Sales Specialist

Full-Time
$85.6k - $117.7k+ Commission
Senior
Bachelor's
Milwaukee, WI, USA+3 moreMore locations: Twin Cities, MN, USA | Michigan, USA | Traverse City, MI, USA
RemoteTravel within the assigned territory; travel is 75% of the time.
Sales & Account ManagementField Sales
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A minimum of a Bachelor of Arts or Bachelor of Science degree in business, marketing, or medical health sciences such as medical technology, biology, or clinical chemistry.
  • At least five years of capital sales experience, preferably in clinical diagnostics.
  • Technical knowledge and the ability to organize and prioritize departmental personnel and tasks.
  • Familiarity with customer relationship management systems and proficiency with the Microsoft Office suite.
  • Willingness to travel within the assigned geography; travel is 75% of the time.
Responsibilities
  • Lead the sales strategy for the IMMULITE portfolio in the assigned geography and work with the laboratory diagnostics sales force to integrate IMMULITE solutions into clinical laboratories.
  • Achieve revenue targets and expand market share by managing the sales cycle from lead generation to close, using Siemens’ customer relationship management tool to track and report sales activities.
  • Build and maintain relationships with laboratory personnel, healthcare providers, and industry opinion leaders.
  • Work cross-functionally with Sales, Marketing, Scientific Support, the Technical Applications Organization, and Customer Service to ensure customer satisfaction.
  • Identify new prospects and position Siemens solutions to win accounts and increase market share.
  • Manage the installed base of Siemens systems and increase revenue, particularly through penetration with newly launched assays.
  • Coordinate sales activities, including technical presentations on Siemens Healthineers instruments and assays, financial proposals, customer references and site visits, competitive positioning, equipment demonstrations, contracting and negotiation, and customer support through implementation after a sale closes.
  • Work with the DX sales force to develop newly installed customers into reference accounts; implement plans to exceed revenue and growth expectations, maximize customer profitability, and ensure customer satisfaction and loyalty; and cultivate long-term relationships with key account decision makers.
  • Maintain a deep understanding of Siemens clinical products and services, relevant market trends, and competitive landscapes.
  • Execute demand-generation campaigns to grow key market segments by positioning the clinical relevance of offered solutions.
  • Analyze internal and external data sources to provide market and customer insights and communicate trends to management.
  • Travel within the assigned territory to meet customers, attend sales events, and participate in training.
  • Use analytical tools for funnel building, customer relationship management, and market insights to provide transparency to internal stakeholders and decision makers.
Desired Qualifications
  • Knowledge of assigned disease states, laboratory practices, and competitive testing methodologies.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Wellness Program
  • 401(k) Retirement Plan

Growth & Insights and Company News

6 month growth

2%

1 year growth

3%

2 year growth

3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.